l ablation dans les ablation dans les l arythmies
play

L ABLATION DANS LES ABLATION DANS LES L ARYTHMIES ARYTHMIES SUPRAVENTRICULAIRES SUPRAVENTRICULAIRES PROF L DE ROY UNIVERSITE DE LOUVAIN BELGIQUE AV NODE ABLATION AV NODE ABLATION RF ON ACCESSORY PATHWAYS ACCESSORY PATHWAYS RF

0 downloads 7 Views 2,18 MB Size Report
  1. L’ ’ ABLATION DANS LES ABLATION DANS LES L ARYTHMIES ARYTHMIES SUPRAVENTRICULAIRES SUPRAVENTRICULAIRES PROF L DE ROY UNIVERSITE DE LOUVAIN BELGIQUE

  2. AV NODE ABLATION AV NODE ABLATION RF ON

  3. ACCESSORY PATHWAYS ACCESSORY PATHWAYS

  4. RF ON P., A. (840120)

  5. 511026 A A A A A A A RF ON

  6. ACCESSORY PATHWAYS ACCESSORY PATHWAYS Palpitations : HR : 260 - 280/min AF : CL < 180 ms Syncope : 11 - 29 % Cardiac arrest : 0.15-0.39 % (3-10y) (1/1000 pts y) RF ABL. : Success : 95 % Recurrences : 5 % Munger circ 1993 Leitch circ 1990 Calkins circ 1999 Lesh JACC 1993

  7. ACC/AHA/ESC Guidelines for Management of Patients With Supraventricular Arrhythmias 2003

  8. AV NODAL TACHYCARDIA S/F:77% S/F:77% S/S:11% S/S:11% F/S:12% F/S:12%

  9. L. M. 380522 / 98153 L. M. 380522 / 98153 25 mm/sec

  10. AVN

  11. AV NODAL TACHYCARDIA Palpitations : HR : 240/min AF Syncopes : 33 - 39 % Cardiac arrest : anecdotal RF ABL. : Success : 96.1 % Recurrences : 3-7 % Scheinman Pace 2000 Clague Eur H J 2001

  12. ACC/AHA/ESC Guidelines for Management of Patients With Supraventricular Arrhythmias 2003

  13. FLUTTER AURICULAIRE FLUTTER AURICULAIRE • FLUTTER ISTHMIQUE ANTIHORAIRE HORAIRE • FLUTTER ATYPIQUE CICATRICIEL AUTRES

  14. Halo cath. Coronary sinus cath. Coronary sinus cath. Halo cath. Ablation cath. Ablation cath. RAO LAO

  15. RF ON L. C. 541212 (22-11-2000)

  16. RF ON L. C. 541212 (22-11-2000)

  17. Natale

  18. Survival rate from recurrent typical atrial flutter (AFl) and atrial fibrillation (AF). * * * * Calkins H et al N: 150 pts Am J Cardiol. 2004 Aug 15;94(4):437-42.

  19. ACC/AHA/ESC Guidelines for Management of Patients With Supraventricular Arrhythmias 2003

  20. M. Scheinman et al Pace 2000;23:1020-1028

  21. FIBRILLATION AURICULAIRE FIBRILLATION AURICULAIRE • FA PAROXYSTIQUE • FA PERSISTANTE • FA PERMANENTE

  22. Haissaguerre M. et al. NEJM 1998;339:659-66

  23. Initiation of AF by ectopic beats from pulmonary veins Haissaguerre M. et al. NEJM 1998;339:659-66

  24. RAO 30 lAO 40

  25. RF ON

  26. LA RA RIPV

  27. Hakan Oral, MD (Circulation. 2002;105:1077.)

  28. FREEDOM FROM RECURRENT PAF AFTER SEGMENTAL OSTIAL ABLATION (SOA, SOLID LINE) AND LEFT ATRIAL CATHETER ABLATION (LACA, DASHED LINE). Oral H Circulation. 2003 Nov 11;108(19):2355-60

  29. LONG-TERM RESULTS OF RF ABLATION FOR AF : IS IT WORTHWHILE ? Results : • Mean FU: 10.1 M (2- 36) • Absence of AF recurrences: 70% w/o AAD: 31% with AAD: 69% • If recurrences: >50% had impressive reduction of AF episodes. • Global improvement: 82% • Quality of life (grading scale from 1 to 10 (1 meaning excellent, 10 very bad): score of 7.3 before to 3.4 after ABL. • We observed 4.5 % significant PV stenoses.

  30. FREEDOM FROM RECURRENT AF AFTER INTEGRATED APPROACH (DASHED LINE) AND ANATOMICAL APPROACH (SOLID LINE). INTEGRATED APPROACH ANATOMICAL APPROACH ROBERTO MANTOVAN, M.D. et al Journal of Cardiovascular Electrophysiology 2005

  31. WORLD WIDE SURVEY AF ABLATION R. Cappato et al Circulation 2005;111:1100-1105

  32. CATHETER ABLATION FOR CURE OF ATRIAL FIBRILLATION CATHETER ABLATION FOR CURE OF ATRIAL FIBRILLATION 137 pts ABL + AAD AAD 69 68 91 % 44 % p: < .001 NO RECUR: (FU: 12.5M) ACC 2005 CACAF study

  33. RF ABL vs vs MED as MED as FIRST LINE FIRST LINE TREATMENT TREATMENT RF ABL AF RECCURENCES AF RECCURENCES O Wazni et al. JAMA 2005

  34. CONCLUSIONS CONCLUSIONS • L’ABLATION EST UNE TECHNIQUE EXTREMEMENT EFFICACE POUR LE TRAITEMENT DES ARYTHMIES SUPRAVENTRICULAIRES • LES COMPLICATIONS SONT DEVENUES RARES DANS DES MAINS EXPERIMENTEES • LA PLUPART DES ARYTHMIES SV SONT ACTUELLEMENT CONSIDEREES COMME DES INDICATIONS DE CL I • LA FA EST DEVENUE UNE ALTERNATIVE SERIEUSE AU TRAITEMENT MEDICAMENTEUX MAIS NECESSITE UNE GRANDE EXPERIENCE POUR EVITER CERTAINES COMPLICATIONS DONT L’ INCIDENCE EST ACTUELLEMENT FORTEMENT REDUITE

Recommend Documents


the w hat w hy and how of long term data preservation
The w hat, w hy and how of long-term

The w hat, w hy and how of long-term data preservation Ingrid Dillo Deputy

thermal ablation
THERMAL ABLATION TATO SYSTEM Laura

THERMAL ABLATION TATO SYSTEM Laura Sarti Product Specialist 1 Definition

disclosure
Disclosure Ablation and Devices for

10/10/19 Disclosure Ablation and Devices for Atrial Fibrillation

no conflict of
NO CONFLICT OF Associate Chief,

Mapping and ablation of Junctional Mapping and ablation of Junctional Mapping

catheter ablation of af
Catheter Ablation of AF 35% Expected

9/11/2019 Catheter Ablation of Atrial Fibrillation 1 APAF 2 STOPAF 70%

microwave ablation and ire
Microwave Ablation and IRE Damian E.

Microwave Ablation and IRE Damian E. Dupuy, M.D., FACR Professor Diagnostic

1
1 9/14/2019 Road Map - Innovations to

9/14/2019 Disclosures I have disclosed relationships with the following

probl emes inverses a la fronti ere pour l equation de
Probl` emes inverses ` a la fronti`

Probl` emes inverses ` a la fronti` ere pour l equation de Beltrami dans

m
M arcel Aym est n le 29 mars 1902

Marcel Aym (1902-1967) 1 Biographie M arcel Aym est n le 29 mars 1902

a
A whose prevalence increases with

Surgical and Concomitant Epicardial- Endocardial (Hybrid) Ablation of

adjuvant therapy of thyroid cancer
Adjuvant Therapy of Thyroid Cancer:

Adjuvant Therapy of Thyroid Cancer: rhTSH, RAI, EBRT and Targeted Therapeutics

progress in fielding a zero focus shadowgraph system for
Progress in Fielding a Zero- Focus

Progress in Fielding a Zero- Focus Shadowgraph System for Ablation

magforce usa fighting cancer with nanotherm therapy
MAGFORCE USA FIGHTING CANCER WITH

MAGFORCE USA FIGHTING CANCER WITH NANOTHERM THERAPY SPARED CRN Meeting May

radiofrequency ablation
RADIOFREQUENCY ABLATION ELIZABETH

RADIOFREQUENCY ABLATION ELIZABETH DAVID MD FRCPC VASCULAR AND INTERVENTIONAL

a new amp exciting technology
A New & Exciting Technology

Visualase Therapy: A New & Exciting Technology Jessica Anne Wilden MD

what are my treatment options for af
What Are My Treatment Options for AF?

What Are My Treatment Options for AF? Mikhael El-Chami, MD FACC, FHRS Emory

radiology presentation schedule
Radiology Presentation Schedule

Beth Israel Deaconess Medical Center Radiology Presentation Schedule Sunday,

laser rework capabilities
Laser Rework Capabilities Utilizing

Laser Rework Capabilities Utilizing different laser wavelengths allow for

investor presentation 4q 2018 stereotaxis at a glance
Investor Presentation 4Q 2018

Investor Presentation 4Q 2018 Stereotaxis at a Glance Global Leader in

permanent tachyc cardi ardias as permanent tachy
Permanent Tachyc cardi ardias as

Permanent Tachyc cardi ardias as Permanent Tachy J J. . Janou Janou ek

fibs and flutters the heart of the matter anita ralstin
Fibs and Flutters: The Heart of the

4/7/13 Fibs and Flutters: The Heart of the Matter Anita Ralstin, CNP By the

transformer ablation studies
Transformer Ablation Studies Simon

. . . . . . . . . . . . . . . . Transformer Ablation Studies